Abstract
Introduction: Lung cancer is the second most common neoplasm worldwide and the most lethal. The low survival rate is attributed to late-stage diagnosis, which is the primary factor influencing the patient's prognosis. Currently, strategies based on the analysis of body fluids (liquid biopsy) are increasingly being used; however, the application of this type of analysis in screening progra…